Aclarion Delivers Strong Q1 2026 Results with 196% Annual Scan Volume Growth Reflecting Accelerating Clinical Adoption
Go back to Aclarion Delivers Strong Q1 2026 Results with 196% Annual Scan Volume Growth Reflecting Accelerating Clinical Adoption| (NASDAQ: ACON) | Delayed: 3.05 +0.01 (0.33%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.04 | 52 Week High | $ | |||
| Open | $2.97 | 52 Week Low | $ | |||
| Day High | $3.05 | P/E | N/A | |||
| Day Low | $2.97 | EPS | $ | |||
| Volume | 7,245 | |||||
| (NASDAQ: ACONW) | Delayed: 0.03 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.03 | 52 Week High | $ | |||
| Open | $0.03 | 52 Week Low | $ | |||
| Day High | $0.03 | P/E | N/A | |||
| Day Low | $0.03 | EPS | $ | |||
| Volume | 1,412 | |||||

